161 related articles for article (PubMed ID: 35372896)
1.
Ma L; Palmer ND; Choi YA; Murea M; Snipes JA; Parks JS; Langefeld CD; Freedman BI
Kidney360; 2020 Dec; 1(12):1353-1362. PubMed ID: 35372896
[TBL] [Abstract][Full Text] [Related]
2. An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.
Li D; Snipes JA; Murea M; Molina AJA; Divers J; Freedman BI; Ma L; Petrovic S
Am J Nephrol; 2020; 51(9):695-704. PubMed ID: 32866949
[TBL] [Abstract][Full Text] [Related]
3. APOL1 Kidney Risk Variants Induce Cell Death
Shah SS; Lannon H; Dias L; Zhang JY; Alper SL; Pollak MR; Friedman DJ
J Am Soc Nephrol; 2019 Dec; 30(12):2355-2368. PubMed ID: 31558683
[TBL] [Abstract][Full Text] [Related]
4. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
5.
Ma L; Chou JW; Snipes JA; Bharadwaj MS; Craddock AL; Cheng D; Weckerle A; Petrovic S; Hicks PJ; Hemal AK; Hawkins GA; Miller LD; Molina AJ; Langefeld CD; Murea M; Parks JS; Freedman BI
J Am Soc Nephrol; 2017 Apr; 28(4):1093-1105. PubMed ID: 27821631
[No Abstract] [Full Text] [Related]
6. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
[TBL] [Abstract][Full Text] [Related]
7. Kidney Disease-Associated
Datta S; Kataria R; Zhang JY; Moore S; Petitpas K; Mohamed A; Zahler N; Pollak MR; Olabisi OA
J Am Soc Nephrol; 2020 Sep; 31(9):2083-2096. PubMed ID: 32675303
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
9. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.
McCarthy GM; Blasio A; Donovan OG; Schaller LB; Bock-Hughes A; Magraner JM; Suh JH; Tattersfield CF; Stillman IE; Shah SS; Zsengeller ZK; Subramanian B; Friedman DJ; Pollak MR
Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34350953
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
[TBL] [Abstract][Full Text] [Related]
11.
Ma L; Ainsworth HC; Snipes JA; Murea M; Choi YA; Langefeld CD; Parks JS; Bharadwaj MS; Chou JW; Hemal AK; Petrovic S; Craddock AL; Cheng D; Hawkins GA; Miller LD; Hicks PJ; Saleem MA; Divers J; Molina AJA; Freedman BI
Kidney Int Rep; 2020 Jun; 5(6):891-904. PubMed ID: 32518871
[TBL] [Abstract][Full Text] [Related]
12. A focus on the association of Apol1 with kidney disease in children.
Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
[TBL] [Abstract][Full Text] [Related]
14. DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.
Chun J; Riella CV; Chung H; Shah SS; Wang M; Magraner JM; Ribas GT; Ribas HT; Zhang JY; Alper SL; Friedman DJ; Pollak MR
J Am Soc Nephrol; 2022 May; 33(5):889-907. PubMed ID: 35232775
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
16. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
O'Toole JF; Schilling W; Kunze D; Madhavan SM; Konieczkowski M; Gu Y; Luo L; Wu Z; Bruggeman LA; Sedor JR
J Am Soc Nephrol; 2018 Mar; 29(3):869-879. PubMed ID: 29180397
[TBL] [Abstract][Full Text] [Related]
17. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
[TBL] [Abstract][Full Text] [Related]
18. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
[TBL] [Abstract][Full Text] [Related]
19. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Bruggeman LA; O'Toole JF; Sedor JR
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F1-F8. PubMed ID: 30332315
[TBL] [Abstract][Full Text] [Related]
20. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
